{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:31:13Z","timestamp":1790397073267,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bristol-Myers Squibb\/Pfizer Spain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study assessed the sociodemographic, functional, and clinical determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation (NVAF) attended in the internal medicine setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A multicenter, cross-sectional study was conducted in NVAF patients who attended internal medicine departments for either a routine visit (outpatients) or hospitalization (inpatients).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 961 patients were evaluated. Their antithrombotic management included: no treatment (4.7%), vitamin K antagonists (VKAs) (59.6%), direct oral anticoagulants (DOACs) (21.6%), antiplatelets (6.6%), and antiplatelets plus anticoagulants (7.5%). Permanent NVAF and congestive heart failure were associated with preferential use of oral anticoagulation over antiplatelets, while intermediate-to high-mortality risk according to the PROFUND index was associated with a higher likelihood of using antiplatelet therapy instead of oral anticoagulation. Longer disease duration and institutionalization were identified as determinants of VKA use over DOACs. Female gender, higher education, and having suffered a stroke determined a preferential use of DOACs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This real-world study showed that most elderly NVAF patients received oral anticoagulation, mainly VKAs, while DOACs remained underused. Antiplatelets were still offered to a proportion of patients. Longer duration of NVAF and institutionalization were identified as determinants of VKA use over DOACs. A poor prognosis according to the PROFUND index was identified as a factor preventing the use of oral anticoagulation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02019-0","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T08:03:24Z","timestamp":1628496204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-6051","authenticated-orcid":false,"given":"Jose Mar\u00eda","family":"Mostaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrio","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PERFILAR study investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Javier S\u00e1nchez","family":"Lora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Iba\u00f1ez Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Jurado Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salgado Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rivera Civico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"D\u00edez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ja\u00e9n \u00c1guila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gerald\u00eda Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Peral Guti\u00e9rrez-Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Astudillo Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ferrando Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Garc\u00eda Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"S\u00e1nchez Cembell\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"L\u00f3pez Caleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixto","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melchor","family":"Rodr\u00edguez Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Conde Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Hern\u00e1ndez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Abascal Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"P\u00e9rez del Molino Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Fern\u00e1ndez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Mart\u00ednez Acitores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel Seisdedos","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Abad Manteca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Budi\u00f1o S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Javier","family":"Moreno Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Coca Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"S\u00e1nchez Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Ruiz Rib\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Mascar\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Morcillo Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Auguet Quintill\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesz","family":"Marim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Fern\u00e1ndez Sol\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Suri\u00f1ach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Marchena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Riera-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Armario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferr\u00e1n","family":"Garc\u00eda Bragado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"del Molino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Sacrist\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Almagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conxita","family":"Falg\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9 Mu\u00f1oz","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Riesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Romero Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Ar\u00e9valo Lorido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Chiquero Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Pijerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fern\u00e1ndez Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Gonz\u00e1lez Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Jes\u00fas","family":"N\u00fa\u00f1ez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"De La Fuente Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"D\u00edaz Peromingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Fern\u00e1ndez Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Daroca P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castiella Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cruz","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"G\u00f3mez Cerezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Pontes Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Felipe","family":"Varona Arche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ferreiro L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Mu\u00f1oz Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Manuel","family":"Casado Cerrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Pilar","family":"Fidalgo Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Casas Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Herreros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cuevas Tasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mui\u00f1o Miguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Marrero Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"S\u00e1nchez \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Catal\u00e1n Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Fresco Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Anuzita Alegr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Artero Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Segu\u00ed Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bonilla Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Maestre Peiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.recesp.2011.08.008","volume":"65","author":"V Barrios","year":"2012","unstructured":"Barrios V, Calderon A, Escobar C, de la Figuera M. Patients with atrial fibrillation in a primary care setting: Val-FAAP study. Rev Esp Cardiol (Engl Ed). 2012;65:47\u201353.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"Suppl 1","key":"2019_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1538-7836.2011.04302.x","volume":"9","author":"GY Lip","year":"2011","unstructured":"Lip GY. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost. 2011;9(Suppl 1):344\u201351.","journal-title":"J Thromb Haemost"},{"key":"2019_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1474-4422(07)70264-8","volume":"6","author":"GY Lip","year":"2007","unstructured":"Lip GY, Lim HS. Atrial fibrillation and stroke prevention. Lancet Neurol. 2007;6:981\u201393.","journal-title":"Lancet Neurol"},{"key":"2019_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983\u20138.","journal-title":"Stroke"},{"key":"2019_CR5","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.ehj.2004.06.030","volume":"25","author":"C Steger","year":"2004","unstructured":"Steger C, Pratter A, Martinek-Bregel M, Avanzini M, Valentin A, Slany J, et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J. 2004;25:1734\u201340.","journal-title":"Eur Heart J"},{"key":"2019_CR6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","volume":"37","author":"K Lakshminarayan","year":"2006","unstructured":"Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke. 2006;37:1969\u201374.","journal-title":"Stroke"},{"key":"2019_CR7","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","volume":"147","author":"PA Wolf","year":"1987","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147:1561\u20134.","journal-title":"Arch Intern Med"},{"key":"2019_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263\u201372.","journal-title":"Chest"},{"key":"2019_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"key":"2019_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/TCRM.S84210","volume":"11","author":"YH Mekaj","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967\u201377.","journal-title":"Ther Clin Risk Manag"},{"key":"2019_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","volume":"364","author":"SJ Connolly","year":"2011","unstructured":"Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364:806\u201317.","journal-title":"N Engl J Med"},{"key":"2019_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"key":"2019_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883\u201391.","journal-title":"N Engl J Med"},{"key":"2019_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955\u201362.","journal-title":"Lancet"},{"key":"2019_CR15","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093\u2013104.","journal-title":"N Engl J Med"},{"key":"2019_CR16","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"2019_CR17","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:1330\u201393.","journal-title":"Eur Heart J"},{"key":"2019_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1160\/TH13-12-1007","volume":"111","author":"JY Le Heuzey","year":"2014","unstructured":"Le Heuzey JY, Ammentorp B, Darius H, De Caterina R, Schilling RJ, Schmitt J, et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry. Thromb Haemost. 2014;111:833\u201341.","journal-title":"Thromb Haemost."},{"key":"2019_CR19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1160\/TH11-11-0768","volume":"107","author":"T Wilke","year":"2012","unstructured":"Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Oral anticoagulation use by patients with atrial fibrillation in Germany Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients. Thromb Haemost. 2012;107:1053\u201365.","journal-title":"Thromb Haemost"},{"key":"2019_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.114.013267","volume":"132","author":"M Sharma","year":"2015","unstructured":"Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-analysis. Circulation. 2015;132:194\u2013204.","journal-title":"Circulation"},{"key":"2019_CR21","doi-asserted-by":"publisher","first-page":"693740","DOI":"10.1155\/2014\/693740","volume":"2014","author":"P Denoel","year":"2014","unstructured":"Denoel P, Vanderstraeten J, Mols P, Pepersack T. Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly? J Aging Res. 2014;2014:693740.","journal-title":"J Aging Res"},{"key":"2019_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0025-7753(01)72040-4","volume":"117","author":"J Martinez de la Iglesia","year":"2001","unstructured":"Martinez de la Iglesia J, Duenas Herrero R, Onis Vilches MC, Aguado Taberne C, Albert Colomer C, Luque Luque R. Spanish language adaptation and validation of the Pfeiffer\u2019s questionnaire (SPMSQ) to detect cognitive deterioration in people over 65 years of age [Adaptacion y validacion al castellano del cuestionario de Pfeiffer (SPMSQ) para detectar la existencia de deterioro cognitivo en personas mayores de 65 anos]. Med Clin (Barc). 2001;117:129\u201334.","journal-title":"Med Clin (Barc)"},{"key":"2019_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","volume":"23","author":"E Pfeiffer","year":"1975","unstructured":"Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433\u201341.","journal-title":"J Am Geriatr Soc"},{"key":"2019_CR24","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J"},{"key":"2019_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"2019_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejim.2010.11.012","volume":"22","author":"M Bernabeu-Wittel","year":"2011","unstructured":"Bernabeu-Wittel M, Ollero-Baturone M, Moreno-Gavino L, Baron-Franco B, Fuertes A, Murcia-Zaragoza J, et al. Development of a new predictive model for polypathological patients. The PROFUND index. Eur J Intern Med. 2011;22:311\u20137.","journal-title":"Eur J Intern Med"},{"key":"2019_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093\u2013100.","journal-title":"Chest"},{"key":"2019_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.STR.0000209239.71702.ce","volume":"37","author":"EM Hylek","year":"2006","unstructured":"Hylek EM, D\u2019Antonio J, Evans-Molina C, Shea C, Henault LE, Regan S. Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke. 2006;37:1075\u201380.","journal-title":"Stroke"},{"key":"2019_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/ageing\/afr097","volume":"40","author":"D Pugh","year":"2011","unstructured":"Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing. 2011;40:675\u201383.","journal-title":"Age Ageing"},{"key":"2019_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","volume":"118","author":"BF Gage","year":"2005","unstructured":"Gage BF, Birman-Deych E, Kerzner R, Radford MJ, Nilasena DS, Rich MW. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med. 2005;118:612\u20137.","journal-title":"Am J Med"},{"key":"2019_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1345\/aph.1K498","volume":"42","author":"CL Garwood","year":"2008","unstructured":"Garwood CL, Corbett TL. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother. 2008;42:523\u201332.","journal-title":"Ann Pharmacother"},{"key":"2019_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","volume":"151","author":"DE Singer","year":"2009","unstructured":"Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009;151:297\u2013305.","journal-title":"Ann Intern Med"},{"key":"2019_CR33","first-page":"231","volume":"22","author":"VSJ Hern\u00e1ndez","year":"2015","unstructured":"Hern\u00e1ndez VSJ, Mazoteras V, L\u00f3pez MT. Underuse of oral anticoagulation in octogenarian patient with atrial fibrillation: a perspective from real clinical practice. Rev Colom Cardiol. 2015;22:231\u20134.","journal-title":"Rev Colom Cardiol"},{"key":"2019_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ageing\/afx103","volume":"47","author":"Y Bai","year":"2018","unstructured":"Bai Y, Guo SD, Deng H, Shantsila A, Fauchier L, Ma CS, et al. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis. Age Ageing. 2018;47:9\u201317.","journal-title":"Age Ageing"},{"key":"2019_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","volume":"69","author":"MV Huisman","year":"2017","unstructured":"Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, et al. The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2. J Am Coll Cardiol. 2017;69:777\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"2019_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2217\/fca-2018-0009","volume":"15","author":"LD Esposti","year":"2019","unstructured":"Esposti LD, Briere JB, Bowrin K, Diego S, Perrone V, Pasquale GD. Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study. Future Cardiol. 2019;15:109\u201318.","journal-title":"Future Cardiol"},{"key":"2019_CR37","doi-asserted-by":"publisher","first-page":"e015363","DOI":"10.1136\/bmjopen-2016-015363","volume":"7","author":"L Lacoin","year":"2017","unstructured":"Lacoin L, Lumley M, Ridha E, Pereira M, McDonald L, Ramagopalan S, et al. Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open. 2017;7:e015363.","journal-title":"BMJ Open"},{"key":"2019_CR38","doi-asserted-by":"crossref","unstructured":"Gullon A, Suarez C, Diez-Manglano J, Formiga F, Cepeda JM, Pose A, et al. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry [Caracteristicas y tratamiento antitrombotico de los pacientes ancianos con fibrilacion auricular no valvular hospitalizados en Medicina Interna. Registro NONAVASC]. Med Clin (Barc). 2017;148:204\u201310.","DOI":"10.1016\/j.medcli.2016.10.042"},{"key":"2019_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jacc.2009.05.046","volume":"54","author":"D Poli","year":"2009","unstructured":"Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol. 2009;54:999\u20131002.","journal-title":"J Am Coll Cardiol"},{"key":"2019_CR40","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","volume":"33","author":"L Friberg","year":"2012","unstructured":"Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500\u201310.","journal-title":"Eur Heart J"},{"key":"2019_CR41","first-page":"3265","volume":"36","author":"GY Lip","year":"2015","unstructured":"Lip GY, Lane DA. Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. Eur Heart J. 2015;36:3265\u20137.","journal-title":"Eur Heart J"},{"key":"2019_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"J Mant","year":"2007","unstructured":"Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370:493\u2013503.","journal-title":"Lancet"},{"key":"2019_CR43","doi-asserted-by":"crossref","unstructured":"Polo Garcia J, Vargas Ortega D, Formiga F, Unzueta I, Fernandez de Cabo S, Chaves J. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain. Semergen. 2018.","DOI":"10.1016\/j.semerg.2018.10.005"},{"key":"2019_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.medcli.2011.05.023","volume":"138","author":"A Lopez Soto","year":"2012","unstructured":"Lopez Soto A, Formiga F, Bosch X, Garcia AJ. Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study [Prevalencia de la fibrilacion auricular y factores relacionados en pacientes ancianos hospitalizados: estudio ESFINGE]. Med Clin (Barc). 2012;138:231\u20137.","journal-title":"Med Clin (Barc)"},{"key":"2019_CR45","doi-asserted-by":"crossref","unstructured":"Lobos-Bejarano JM, del Castillo-Rodriguez JC, Mena-Gonzalez A, Aleman-Sanchez JJ, Cabrera de Leon A, Baron-Esquivias G, et al. Patients' characteristics and clinical management of atrial fibrillation in primary healthcare in Spain: FIATE Study [Caracteristicas de los pacientes y abordaje terapeutico de la fibrilacion auricular en atencion primaria en Espana: Estudio FIATE]. Med Clin (Barc). 2013;141:279\u201386.","DOI":"10.1016\/j.medcli.2012.12.023"},{"key":"2019_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","volume":"9","author":"TP Van Staa","year":"2011","unstructured":"Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost. 2011;9:39\u201348.","journal-title":"J Thromb Haemost"},{"key":"2019_CR47","doi-asserted-by":"crossref","unstructured":"Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, et al. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry. Europace. 2016;18:648\u201357.","DOI":"10.1093\/europace\/euv390"},{"key":"2019_CR48","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37:1591\u2013602.","journal-title":"Eur Heart J"},{"key":"2019_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fphar.2017.00063","volume":"8","author":"CL Rodriguez-Bernal","year":"2017","unstructured":"Rodriguez-Bernal CL, Hurtado I, Garcia-Sempere A, Peiro S, Sanfelix-Gimeno G. Oral anticoagulants initiation in patients with atrial fibrillation: real-world data from a population-based cohort. Front Pharmacol. 2017;8:63.","journal-title":"Front Pharmacol"},{"key":"2019_CR50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/1074248415596426","volume":"21","author":"J Moreno-Arribas","year":"2016","unstructured":"Moreno-Arribas J, Bertomeu-Gonzalez V, Anguita-Sanchez M, Cequier A, Muniz J, Castillo J, et al. Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study. J Cardiovasc Pharmacol Ther. 2016;21:150\u20136.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2019_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.semerg.2016.09.003","volume":"43","author":"V Barrios","year":"2017","unstructured":"Barrios V, Escobar C, Lobos JM, Polo J, Vargas D. Use of non-vitamin K antagonist oral anticoagulants in Primary Care: ACTUA study [Uso de los anticoagulantes orales de accion directa en atencion primaria: Estudio ACTUA]. SEMERGEN. 2017;43:477\u201385.","journal-title":"SEMERGEN"},{"key":"2019_CR52","unstructured":"Agencia Espa\u00f1ola de Medicamento y Productos Sanitarios (AEMPS). Criterios y recomendaciones para el uso de nuevos anticoagulantes orales (NACO) en la prevenci\u00f3n del ictus y la embolia sist\u00e9mica en pacientes con fibrilaci\u00f3n auricular no valvular. Informe de Posicionamiento Terap\u00e9utico UT\/V4\/23122013. 2016. Available from: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/informesPublicos\/home.htm#anticoagulantes-orales."},{"key":"2019_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/europace\/euu225","volume":"17","author":"JB Olesen","year":"2015","unstructured":"Olesen JB, Sorensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, et al. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011\u20132013. Europace. 2015;17:187\u201393.","journal-title":"Europace"},{"key":"2019_CR54","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40266-017-0476-4","volume":"34","author":"AM Urbaniak","year":"2017","unstructured":"Urbaniak AM, Strom BO, Krontveit R, Svanqvist KH. Prescription patterns of non-vitamin K oral anticoagulants across indications and factors associated with their increased prescribing in atrial fibrillation between 2012\u20132015: a study from the norwegian prescription database. Drugs Aging. 2017;34:635\u201345.","journal-title":"Drugs Aging"},{"key":"2019_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ahj.2017.03.024","volume":"189","author":"BA Steinberg","year":"2017","unstructured":"Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, et al. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2017;189:40\u20137.","journal-title":"Am Heart J"},{"key":"2019_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-0035-1550158","volume":"41","author":"P Ho","year":"2015","unstructured":"Ho P, Brooy BL, Hayes L, Lim WK. Direct oral anticoagulants in frail older adults: a geriatric perspective. Semin Thromb Hemost. 2015;41:389\u201394.","journal-title":"Semin Thromb Hemost"},{"key":"2019_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/IJGM.S5870","volume":"2","author":"M Pather","year":"2009","unstructured":"Pather M. The prevalence of renal impairment in the elderly hospitalized population. Int J Gen Med. 2009;2:117\u20139.","journal-title":"Int J Gen Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02019-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02019-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02019-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T08:11:52Z","timestamp":1628496712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02019-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02019-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"21 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Independent Ethics Committee of La Princesa University Hospital (Madrid, Spain), and written informed consent was obtained from all patients before they were included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as this manuscript does not contain any person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C. Suarez has received speaker honoraria or advisory board fees from BMS\/Pfizer, Bayer, and Daiichi Sankyo. J.M. Cepeda has received speaker honoraria and advisory board fees from BMS\/Pfizer, Bayer, and Daiichi Sankyo. L. Manzano has received speaker honoraria or advisory board fees from BMS\/Pfizer, Bayer, Boehringer Ingelheim and Daiichi Sankyo. D. S\u00e1nchez has received payments from collaborations with Bayer, BMS\/Pfizer, Boehringer Ingelheim and Daiichi Sankyo. J.M. Mostaza declares that he does not have any conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}